TL;DR
The feasibility of integrating Edge AI with microfluidic biosensing concepts for low-latency and energy-aware monitoring of critical biomarkers is demonstrated and full analytical and device-level validation remains future work.
This work connects biomedical signal capture, on-device AI, clinical translation, and digital ethics to delineate a roadmap for frontier AI wearables, and proposed edge-aware transformer-based models, privacy-preserving analytics, and global multimodal sensing advance intelligent, scalable, and fair AI-driven health mo...
Wearable healthcare electronics have become widespread and rapid advancement of this technology has pushed for intelligent, real-time and non-invasive biosensing technologies. The traditional wearable sensors are generally low in sensitivity, susceptible to electromagnetic interference, and consume too much energy, whi...
The main findings reveal that nanosensor-enabled systems can significantly enhance diagnostic performance, with graphene-based nanosensors detecting C-reactive protein in human serum at concentrations near 27 pM, and plasmonic sensors offering swift, portable detection.
Clinical translation remains limited by data security and privacy risks, insufficient standardization and regulatory alignment, long-term stability and biocompatibility concerns, and uneven validation maturity across technologies.
By linking molecular-level recognition with computational signal interpretation, this review highlights the advantages and limitations of artificial intelligence-integrated biosensors for next-generation point-of-care diagnostics, continuous health monitoring, and personalized healthcare applications.
This review provides a critical chemistry-to-clinical perspective on smart wearable biosensors and outlines the validation, manufacturing, cybersecurity, post-market surveillance and benchmarking requirements needed for their translation into reliable diagnostic and therapeutic-monitoring technologies.
A new computational approach reveals how cells communicate to assemble into tissues. This could accelerate stem cell engineering, improve disease models, and inform therapies.
Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.
By rethinking how large cloud computing systems operate, Associate Professor Christina Delimitrou seeks to make data centers more energy efficient.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.
